832-497-2220 [email protected]

Medical Imaging Equipment

Medical imaging equipment plays an significantaly important role in the development of medical equipment, and represent the high-end industrialization of medical device. To facilitate development of medical imaging equipment, from 2013 to 2019, the Chinese administrative department issued several documents involving medical imaging equipment, independent imaging centers, online imaging platforms, and imaging informatization, etc.

According to China’s overall medical expenditure in the past five years, it is estimated that by 2020, China’s medical imaging market will reach RMB¥600 to RMB¥800 billion (approximately USD$ 85.7 billion to USD$ 114.3 billion).

Furthermore, in “The Thirteenth Five-Year Plan”, the primary goal is to replace imported products; promote the leapfrog development of the industry in localization, high-end, branding, and internationalization.

Submitted Projects:

Project ID: MIE101

Category: Medical Imaging Equipment

Keyword: Diabetic Retinopathy Screening (DRISTi) System

Project/Product Summary:

AI enabled imaging devices

Indications: Diabetes-induced retinopathy

Stage: Prototype

Partnering Objectives: Financing and business cooperation

Country: USA

Project ID: MIE102

Category: Medical Imaging Equipment

Keyword: Noninvasive Acoustic Neuropathology Testing

Project/Product Summary:

Strokes affect 15 million people worldwide, causing hemorrhagic complications, permanent disability, dependency, and death. Project MIE102 is leading the science of objectively diagnosing Large Vessel Occlusion (LVO) ischemic strokes to minimize the delay in care and injury to the brain. We are the leading company focused specifically on the science, development, and commercialization of acoustic-based technologies for the non-invasive detection of neuropathologies. We are passionate about providing objective diagnostics to enhance therapy and time to treatment for patients suffering from ischemic strokes by providing innovative, clinically proven and economically effective diagnostic solutions for physicians and health care providers.

Indications: Stroke

Stage: Prototype

Partnering Objectives: Fundraising, business cooperation

Country: USA

Project ID: MIE103

Category: Medical Imaging Equipment

Keyword: AI-assisted diagnosis of breast cancer

Project/Product Summary:

Mammography is a well-established, cost-effective imaging technique for breast cancer detection that has been clinically available worldwide. It is the only screening technology that was proved to reduce mortality and the only one with FDA clearance.Mammography is a well-established, cost-effective imaging technique for breast cancer detection that has been clinically available worldwide. It is the only screening technology that was proved to reduce mortality and the only one with FDA clearance.The company develops a decision support information Hub and Medical Record platform for the Breast Cancer prevention arena, based on:1. XXX module  focused on young women, CESM (Contrast-Enhanced Spectral Mammography):  The module supports radiologist’s decision when the mammography itself cannot show all details (40% to 50% of women below 50 years have dense breasts as well as a significant proportion of women older than 50 years. The overall sensitivity range of mammography is 63%-98% and drops to 30%-58% for dense breast).
The XXX module developed in the SHEBA Hospital over 3 years, by CILAB and MEIRAV and it cost more than $1M.Under the agreement signed on 2020, the company got all the commercialization rights. The system is in use by the SHEBA Hospital – the clinical POC done at the SHEBA with ~170 cases (more 200 are ready complete) with 66% accuracy as stand alone. Together with the physicians, achieved ~90% and decreased the unnecessary biopsies by 30%.2. Mammography Image Comparison Analysis: shows the new and changes between mammograms over time, using our AI and ML Algorithms3. Mobile App: for patient to store and access their medical images records/information, 2nd opinion, unlimited storage for mammography’s images, MRI, ultrasound, biopsy, etc.

Indications: Breast cancer

Stage: Phase I

Partnering Objectives: Fundraising;JV;Distribution Licensing

Country: Israel

Potential Chinese Partners: